KLC3 drives gastric cancer progression by stabilizing SLC2A5 to activate MAPK signaling and promote epithelial-mesenchymal transition. Ma Z, Ma B, Chen M, He P, et al. BMC Cancer 2025;25:1746.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma Z, Ma B, Chen M, He P, et al. KLC3 drives gastric cancer progression by stabilizing SLC2A5 to activate MAPK signaling and promote epithelial-mesenchymal transition. BMC Cancer 2025;25:1746.
PMID: 41214559